120 related articles for article (PubMed ID: 16465350)
1. Should we be initiating antiretroviral therapy earlier? An argument in favour.
Wood R
S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
[No Abstract] [Full Text] [Related]
2. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
Bucher HC; Wolbers M; Porter K
JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
[No Abstract] [Full Text] [Related]
3. When to start antiretroviral therapy--ready when you are?
Sax PE; Baden LR
N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
[No Abstract] [Full Text] [Related]
4. Early versus deferred antiretroviral therapy for HIV.
Hernán MA; Robins JM
N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
[No Abstract] [Full Text] [Related]
5. Treatment. Individual approach needed for co-infections.
AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
[No Abstract] [Full Text] [Related]
6. HIV survival benefit associated with earlier antiviral therapy.
Mocroft A; Phillips AN; Lundgren JD
Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
[No Abstract] [Full Text] [Related]
7. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
Boulle A; Clayden P; Cohen K; Cohen T; Conradie F; Dong K; Geffen N; Grimwood A; Hurtado R; Kenyon C; Lawn S; Maartens G; Meintjes G; Mendelson M; Murray M; Rangaka M; Sanne I; Spencer D; Taljaard J; Variava E; Venter WD; Wilson D
S Afr Med J; 2010 Sep; 100(9):566, 568, 570-1. PubMed ID: 20822639
[No Abstract] [Full Text] [Related]
8. Early versus deferred antiretroviral therapy for HIV.
Buchbinder SP; Jain V
N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
[No Abstract] [Full Text] [Related]
9. Getting smarter--the toxicity of undertreated HIV infection.
Currier JS; Baden LR
N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
[No Abstract] [Full Text] [Related]
10. Monitoring of antiretroviral therapy in low-resource settings.
Bendavid E
Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
[No Abstract] [Full Text] [Related]
11. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
O'Brien DP; Sauvageot D; Zachariah R; Humblet P;
AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517
[TBL] [Abstract][Full Text] [Related]
12. National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines?
Lawn SD; Wood R
AIDS; 2007 Jan; 21(1):121-2. PubMed ID: 17148984
[No Abstract] [Full Text] [Related]
13. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ;
AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939
[TBL] [Abstract][Full Text] [Related]
14. Timing of antiretroviral drugs during tuberculosis therapy.
Kadhiravan T
N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
[No Abstract] [Full Text] [Related]
15. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
[TBL] [Abstract][Full Text] [Related]
16. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.
Soriano V; Vispo E; Barreiro P
AIDS; 2011 Apr; 25(7):1013-4. PubMed ID: 21487255
[No Abstract] [Full Text] [Related]
17. Timing of antiretroviral drugs during tuberculosis therapy.
Wilson D; Meintjes G
N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
[No Abstract] [Full Text] [Related]
18. Early versus deferred antiretroviral therapy for HIV.
Gelinck LB; van der Ende ME
N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
[No Abstract] [Full Text] [Related]
19. Should the CD4 threshold for starting ART be raised?
Wood R; Lawn SD
Lancet; 2009 Apr; 373(9672):1314-6. PubMed ID: 19361856
[No Abstract] [Full Text] [Related]
20. Trial finds simultaneous HIV/tuberculosis treatment beneficial.
Baleta A
Lancet Infect Dis; 2008 Nov; 8(11):669. PubMed ID: 18992400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
